Affinity Asset Advisors, LLC Infla Rx N.V. Transaction History

Affinity Asset Advisors, LLC

  • $579 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$1.25 - $2.75 $156,250 - $343,750
-125,000 Reduced 38.45%
200,097 $326,000
Q3 2023

Nov 14, 2023
BUY
$2.66 - $4.33 $225,826 - $367,604
84,897 Added 35.34%
325,097 $968,000
Q2 2023

Aug 14, 2023
BUY
$2.05 - $6.1 $492,409 - $1.47 Million
240,200 New
240,200 $1.07 Million

Others Institutions Holding IFRX

# of Institutions
29
Shares Held
12.9M
Call Options Held
19.3K
Put Options Held
0
View Full List

About InflaRx N.V.

IFRX Quotes by TradingView
  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $99M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email